Liver disease is a major health issue which present poor clinical treatment performance.
Cirrhosis and liver failure are common clinical manifestations of liver diseases. Liver …

The therapeutic value of mesenchymal stem cells (MSCs) for the treatment of infectious
diseases and the repair of disease-induced tissue damage has been explored extensively …

Background Accumulating evidence shows that mesenchymal stem cells (MSCs) have the
potential as a cellular therapy avenue for schistosome-induced liver injury. Extracellular …

Background and aims A marked egg-induced CD4+ T cell programmed inflammation and
subsequent hepatic fibrosis characterize the pathogenesis of schistosomiasis. Mesenchymal …

Mesenchymal stem cell (MSCs) therapy are among new strategies that are used to combat
infections through immunomodulation. Cell number, route and frequency of injection and the …

Background In view of the potential immunosuppressive and regenerative properties of
mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue …

Liver diseases are a major health problem worldwide leading to high mortality rates and
causing a considerable economic burden in many countries. Cellular therapies as potential …

Schistosomiasis is a neglected tropical disease with considerable morbidity. The lone
effective drug, praziquantel (PZQ), is showing emergence of drug resistance hence …

Background and Aim: Toxoplasma infection is mainly latent and cause severe disease only
if reactivation occurs especially for brain cysts. This study aimed to evaluate the therapeutic …

Background: Self-renewal, multipotent, and immunomodulatory are properties of
mesenchymal stem cells (MSCs) that make them a good candidate for cell therapy …